TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children

Abroad (travel likely)RecruitingPHASE2

Conditions

Hemoglobinopathy (Disorder) · Severe Aplastic Anemia · Bone Marrow Failure Syndrome

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Johns Hopkins All Children's Hospital, St. Petersburg, Florida, United States
Contact: Study coordinator (Ian Snyder) · isnyder5@jhmi.edu
Contact: Principal Investigator (Deepak Chellapandian, MD)

Study leads

Deepak Chellapandian, MD
Principal Investigator
Johns Hopkins All Children's Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia

Anemia

Abroad (travel likely)RecruitingPHASE2

Halifax, Canada · Guangzhou, China

AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion

Acute Leukemia · Severe Aplastic Anemia · Non-hodgkin Lymphoma

Abroad (travel likely)RecruitingPHASE2

Valhalla, United States

Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling

Sickle Cell Disease · Thalassemia · Hemoglobinopathy

Abroad (travel likely)RecruitingEARLY_PHASE1

Bethesda, United States